antigenetics.com

100 assays

K7432-100

824 EUR

Serum

Human

2-8°C

prostate

gel pack

24 months

Prostate Specific Antigen (PSA) ELISA kit

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Quantitative detection of free Prostate Specific Antigen (PSA)

Antigens are peptides or recombinant or native dependent on the production method.

• Easy, convenient and time-saving method to measure free Prostate Specific Antigen (PSA) • Sensitivity: 0.1 ng/ml

PSA (free, human) ELISA Kit, Gamma-Seminoprotein (free, human) ELISA Kit, kallikrein-3 (free, human) ELISA Kit, KLK3 (free, human) ELISA Kit

• Microwells coated with f-PSA MAb • f-PSA Standard • Anti-f-PSA Conjugate Reagent • Wash Buffer (20X) • TMB Substrate • Stop Solution

• Detection method: Absorbance (450 nm) • Species reactivity: Human • Application: Quantitative detection of free: Prostate Specific Antigen (PSA)

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Human Prostate Specific Antigen (PSA) is a 33 kD serine proteinase which, in human serum, is predominantly bound to alpha 1-antichymotrypsin (PSA-ACT) and alpha 2-macroglobulin (PSAAMG). Trace amounts of alpha 1-antitrypsin and inter-alpha trypsin inhibitor bound to PSA can also be found. Any remaining PSA is in the free form (f-PSA). 1-3 Current methods of screening men for prostate cancer utilize the detection of the major PSA-ACT form. Levels of 4.0 ng/ml or higher are strong indicators of the possibility of prostatic cancer.4 However, elevated serum PSA levels have also been attributed to benign prostatic hyperplasia and prostatitis, leading to a large percentage of false positive screening results.5 A potential solution to this problem involves the determination of free PSA levels.6-17 Preliminary studies have suggested that the percentage of free PSA is lower in patients with prostate cancer than those with benign prostatic hyperplasia.2 Thus, the measurement of free serum PSA in conjunction with total PSA, can improve specificity of prostate cancer screening in selected men with elevated total serum PSA levels, which would subsequently reduce unnecessary prostate biopsies with minimal effects on cancer detection rates. BioVision’s free-PSA kit is a solid phase direct sandwich ELISA method. The samples and diluted anti-f-PSA-HRP conjugate are added to the wells coated with MAb to f-PSA. The f-PSA molecules present in the standard solution or sera are "sandwiched" between the two antibodies. Following the formation of the coated antibody-antigen-antibody-enzyme complex, the unbound protein and HRP-conjugate are washed off by wash buffer. Upon the addition of the substrate, the intensity of color is proportional to the concentration of f-PSA. Sensitivity: 0.1 ng/ml